NHS
Neuberger High Yield Strategies Fund Inc.Marquee-fund ownership over time
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Citadel Advisors | Q3 2024 | Q4 2024 | — | +0% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at Neuberger High Yield Strategies Fund Inc.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from Apr 27, 2026 — the most recent Form 4 on file — not from today.
- Form 40000898432-26-000297Apr 27, 2026
- Form 40000898432-26-000280Apr 24, 2026
- Form 40000898432-25-000495Jul 21, 2025
- Form 40000898432-25-000417May 30, 2025
- Form 40000905148-23-000948Sep 20, 2023
- Form 40001140361-23-033195Jul 5, 2023
- Form 40001140361-23-033194Jul 5, 2023
- Form 40000898432-23-000407Jun 23, 2023
- Form 40000898432-23-000406Jun 23, 2023
- Form 40000898432-23-000405Jun 23, 2023
- Form 40001140361-22-022619Jun 10, 2022
- Form 40001140361-22-022613Jun 10, 2022
- Form 40000898432-22-000385Jun 8, 2022
- Form 40001567619-22-012442Jun 7, 2022
- Form 40000898432-22-000345May 19, 2022
Fundamentals
XBRL · Neuberger High Yield Strategies Fund Inc.Not enough XBRL history to plot. Neuberger High Yield Strategies Fund Inc.hasn't tagged revenue, net income, EPS, or operating cash flow in the SEC us-gaap taxonomy with at least two fiscal-year periods — typical for SPACs / trust vehicles, pre-revenue biotechs, recent IPOs, and foreign filers reporting under IFRS.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for Neuberger High Yield Strategies Fund Inc. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- DEF 14ADEFINITIVE PROXY STATEMENTAug 25, 2025
- SC 13G/AAMENDED SCHEDULE 13GOct 11, 2024
- DEF 14AProxy statementSep 20, 2024
- SC 13G/AAMENDED SCHEDULE 13GJul 12, 2024
- SC 13G/AAMENDED SCHEDULE 13GJan 19, 2024
- SC 13G/AAMENDED SCHEDULE 13GDec 8, 2023
- SC 13G/A5%+ ownership (amended)Nov 15, 2023
- SC 13G5%+ ownership (passive)Oct 6, 2023
- SC 13D/A5%+ ownership (amended)Sep 20, 2023
- DEF 14AProxy statementAug 11, 2023
- SC 13G/A5%+ ownership (amended)Jul 12, 2023
- SC 13G/A5%+ ownership (amended)Mar 27, 2023
- SC 13G/AAMENDED SCHEDULE 13GJan 30, 2023
- SC 13G/A5%+ ownership (amended)Jan 6, 2023
- DEF 14AProxy statementAug 10, 2022
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Citadel Advisors | Q3 2024 | Q4 2024 | $0.00 | — | +0% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.